# Transcode Therapeutics, Inc.: Form 8-K/A, filed Oct 8, 2025

- Company: [Transcode Therapeutics, Inc.](/companies/rnaz.md) (CIK 1829635)
- Form: 8-K/A
- Filed: 2025-10-08
- Accepted by EDGAR: Oct 8, 2025, 20:13 ET
- Period: 2025-10-08
- Accession: 0001104659-25-097919
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925097919/tm2528282d3_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829635/000110465925097919/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829635/000110465925097919/tm2528282d3_8ka.htm

Filed Oct 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-097919. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
